Effectiveness of Foslevodopa/Foscarbidopa in Subgroups of Patients Earlier within Advanced Parkinson’s Disease in an Interim Dataset of ROSSINI (P3-17.005)

Key Points

• This research examines the effectiveness of foslevodopa/foscarbidopa in patients with advanced Parkinson’s disease earlier in their treatment journey.
• Utilized an interim dataset from ROSSINI
• Analyzed real-world evidence from patients with advanced Parkinson’s disease
• Foslevodopa/foscarbidopa demonstrated effectiveness among early-stage advanced Parkinson’s disease patients.
• Improvement in patient outcomes was noted, supporting use in this subgroup.